Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, ...

Investigators examined the comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in a real-world setting.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

Terns' late-stage assets target CML & obesity with key data in Q4 2025. Explore their potential in massive markets. Click ...

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Originally designed to manage type 2 diabetes, the GLP-1 drug Ozempic has become a global phenomenon for its off-label weight ...

Consumers are becoming more concerned about their health, with many prioritising weight loss. But what do they consider to be ...

Lately, Ozempic drugs have taken the world by storm. The drug is touted to be a magical driving force for weight loss.

Nurse practitioners form the key to providing culturally competent care, which improves outcomes for Asian American patients.

For people beginning their weight loss journey, a combination of physical activity and a healthy diet – such as the ...

Hims & Hers will begin offering generic semaglutide drugs in Canada next year after Novo Nordisk lost its exclusive patent ...